Viewing Study NCT06825559


Ignite Creation Date: 2025-12-24 @ 2:49 PM
Ignite Modification Date: 2025-12-24 @ 2:49 PM
Study NCT ID: NCT06825559
Status: RECRUITING
Last Update Posted: 2025-10-24
First Post: 2025-02-09
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease
Sponsor: Zydus Therapeutics Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module